v3.25.3
NOTE 11 - BUSINESS SEGMENT INFORMATION
 9 Months Ended
Sep. 30, 2025
Notes  
NOTE 11 - BUSINESS SEGMENT INFORMATION

NOTE 11 – BUSINESS SEGMENT INFORMATION

 

As of September 30, 2025, the Company operated in two reportable segments (Corporate and Health Supplements) supported by a corporate group which conducts activities that are non-segment specific. The following table presents selected financial information about the Company’s reportable segments for the nine months ended September 30, 2025.

 

 

CONSOLIDATED

HEALTH SUPPLEMENTS

CORPORATE

BergaMet

UBN

Revenue

2,817,910

2,817,910

-

-

Cost of Revenue

1,352,848

1,352,848

-

-

Long-lived Assets

715,141

212,414

502,727

-

Gain (Loss) Before Income Tax

(727,133)

8,140

(300)

(734,973)

Identifiable Assets

966,522

966,522

-

-

Depreciation and Amortization

1,329

1,329

-

-

 

As of September 30, 2024, the Company operated in two reportable segments (Corporate and Health Supplements) supported by a corporate group which conducts activities that are non-segment specific. The following table presents selected financial information about the Company’s reportable segments for the nine months ended September 30, 2024.

 

 

CONSOLIDATED

HEALTH SUPPLEMENTS

CORPORATE

BergaMet

UBN

Revenue

2,342,091

2,342,091

-

-

Cost of Revenue

845,185

845,185

-

-

Long-lived Assets

732,030

193,260

538,771

-

Gain (Loss) Before Income Tax

(393,742)

364,817

(770)

(757,789)

Identifiable Assets

1,443,505

1,443,505

-

-

Depreciation and Amortization

343

343

-

-

 

Currently, all of our customers are located in the United States of American and Canada. Our revenues to our customers are not material to our overall total sales. Our largest customers, Natural Grocers and Emerson Ecologics, LLC, account for less than 1% of our total sales in the nine months ending September 30, 2025 and 2024.